Pathophysiology and Management of Dyslipidemias Associated with Insulin-Resistant States
Insulin resistance (IR), an impaired ability of circulating insulin to promote clearance of glucose from the blood, is common in the United States and other developed countries. It is prevalent among people with obesity, polycystic ovary syndrome, impaire
- PDF / 48,377,147 Bytes
- 687 Pages / 504.63 x 737.01 pts Page_size
- 3 Downloads / 150 Views
Michael H. Davidson Peter P. Toth Kevin C. Maki Editors
Therapeutic Lipidology Second Edition
Contemporary Cardiology Series Editor Peter P. Toth Ciccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University School of Medicine Baltimore, MD USA
For more than a decade, cardiologists have relied on the Contemporary Cardiology series to provide them with forefront medical references on all aspects of cardiology. Each title is carefully crafted by world-renown cardiologists who comprehensively cover the most important topics in this rapidly advancing field. With more than 75 titles in print covering everything from diabetes and cardiovascular disease to the management of acute coronary syndromes, the Contemporary Cardiology series has become the leading reference source for the practice of cardiac care. More information about this series at http://www.springer.com/series/7677
Michael H. Davidson • Peter P. Toth Kevin C. Maki Editors
Therapeutic Lipidology Second Edition
Editors Michael H. Davidson The University of Chicago Pritzker School of Medicine Chicago, IL USA Kevin C. Maki Department of Applied Health Science Indiana University School of Public Health Bloomington, IN USA
Peter P. Toth Cicarrone Center for the Prevention of Cardiovascular Disease Johns Hopkins Univerity School of Medicine Baltimore, MD USA
ISSN 2196-8969 ISSN 2196-8977 (electronic) Contemporary Cardiology ISBN 978-3-030-56513-8 ISBN 978-3-030-56514-5 (eBook) https://doi.org/10.1007/978-3-030-56514-5 © Springer Nature Switzerland AG 2021 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Humana imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Preface
It has been 13 years since the first edition of Therapeutic Lipidology was published.
